CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $12.29B, above the global median of $520.53M
- PositionP/E ratio is 0.94×, lower than 95% of its Medical Care Facilities peers (median 23.68×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
465.03MUSDvs all stocks (USD)
Trailing P/E
0.9363xvs Medical Care Facilities peers
Revenue (TTM)
12.29BUSDvs all stocks (USD)
Profit Margin
3.77%vs Medical Care Facilities peers
Beta
1.81xvs all stocks
52-Week Change
-12.00%vs all stocks
Market Capitalization
465.03MUSDvs all stocks (USD)
Enterprise Value
10.99BUSDvs all stocks (USD)
Trailing P/E
0.9363xvs Medical Care Facilities peers
Forward P/E
30.80xvs Medical Care Facilities peers
PEG Ratio
0.0028xvs Medical Care Facilities peers
Price to Sales (TTM)
0.0388xvs Medical Care Facilities peers
Enterprise to Revenue
0.8940xvs Medical Care Facilities peers
Enterprise to EBITDA
7.93xvs Medical Care Facilities peers
Gross Margin
85.13%vs Medical Care Facilities peers
Profit Margin
3.77%vs Medical Care Facilities peers
Operating Margin
6.44%vs Medical Care Facilities peers
Return on Assets (TTM)
4.68%vs Medical Care Facilities peers
Revenue (TTM)
12.29BUSDvs all stocks (USD)
Revenue per Share (TTM)
91.76USDUpdated Jul 18, 2026Quarterly Revenue Growth
-6.10%vs Medical Care Facilities peers
Gross Profit (TTM)
5.11BUSDvs all stocks (USD)
EBITDA (TTM)
1.46BUSDvs all stocks (USD)
Net Income (TTM)
464.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-6.14%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
126.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
337.88MUSDvs all stocks (USD)
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
557.00MUSDFY2025 · Dec 31, 2025Revenue
12.48BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.86BUSDFY2025 · Dec 31, 2025Gross Profit
10.62BUSDFY2025 · Dec 31, 2025Operating Income
1.08BUSDvs all stocks (USD)
Pre-tax Income
724.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
48.00MUSDFY2025 · Dec 31, 2025Net Income
676.00MUSDFY2025 · Dec 31, 2025EBIT
1.60BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.52BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
5.69BUSDFY2025 · Dec 31, 2025Other Operating Expenses
3.42BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
2.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
872.00MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
676.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-167.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
1.05BUSDFY2025 · Dec 31, 2025Free Cash Flow
719.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
260.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
249.00MUSDFY2025 · Dec 31, 2025Interest Paid
804.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
676.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
426.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-243.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
173.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
99.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-96.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-327.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
1.25BUSDFY2025 · Dec 31, 2025Purchase of Investments
-202.00MUSDFY2025 · Dec 31, 2025Sale of Investments
123.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
847.00MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
2.51BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-6.52BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
3.02BUSDFY2025 · Dec 31, 2025Other Financing Charges
-181.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.17BUSDFY2025 · Dec 31, 2025Shares Outstanding
140.92MSharesUpdated Jul 18, 2026Float Shares
83.11MSharesUpdated Jul 18, 2026Shares Short
12.16MSharesUpdated Jul 18, 2026Short Ratio
8.20daysvs all stocks
Short % of Shares Outstanding
9.34%vs all stocks
% Held by Insiders
15.20%vs all stocks
% Held by Institutions
78.89%vs all stocks
Total Cash (MRQ)
712.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.26USDUpdated Jul 18, 2026Total Debt (MRQ)
10.76BUSDvs all stocks (USD)
Current Ratio (MRQ)
1.47xvs Medical Care Facilities peers
Book Value per Share (MRQ)
-10.73USDUpdated Jul 18, 2026Total Assets
13.20BUSDvs all stocks (USD)
Total Current Assets
3.23BUSDFY2025 · Dec 31, 2025Total Liabilities
14.04BUSDFY2025 · Dec 31, 2025Total Non-current Assets
9.97BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
11.83BUSDFY2025 · Dec 31, 2025Total Current Liabilities
2.21BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
260.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
2.08BUSDFY2025 · Dec 31, 2025Inventory
322.00MUSDFY2025 · Dec 31, 2025Accounts Payable
842.00MUSDFY2025 · Dec 31, 2025Short-term Debt
126.00MUSDFY2025 · Dec 31, 2025Long-term Debt
10.92BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
891.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.00MUSDFY2025 · Dec 31, 2025Retained Earnings
-3.57BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
-837.00MUSDvs all stocks (USD)
52-Week Low
2.38USDUpdated Jul 18, 202652-Week High
4.43USDUpdated Jul 18, 202652-Week Change
-12.00%vs all stocks
Beta
1.81xvs all stocks
50-Day MA
3.06USDUpdated Jul 18, 2026200-Day MA
3.20USDUpdated Jul 18, 2026Avg 10-Day Volume
2.24MSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.70MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
3.61USDUpdated Jul 18, 2026Other Income / Expense
512.00MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Debt Financing Activity
More cash moved through borrowing and repaying than through the business itself, and most of its debt is long-term.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 0.94×, lower than 95% of its Medical Care Facilities peers (median 23.68×)Notable
P/E ratio: 0.94Industry median: 23.68Industry P5: 8.30Peers compared: 70.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 464,000,000Operating Cash Flow (USD, TTM): 126,000,000
High gross margins eroded by operating costsNotable
Gross Margin: 0.85Profit Margin: 0.04
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $12.29B, above the global median of $520.53MNotable
Revenue (USD): 12,291,000,320Global Median: 520,528,949.311
Levered free cash flow is $337.88M, above the global median of $16.24MNotable
Levered free cash flow (USD): 337,875,008Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Praram 9 Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionFlowProduction
Charming Medical Limited
Tier 1RuleThroughput-Bound ConversionProductionInterface
Q & M Dental Group (Singapore) Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Liaoning He Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Auna S.A.
Tier 1RuleThroughput-Bound ConversionRiskProduction
Universal Vision Biotechnology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionInterface
Surfilter Network Technology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionSenseMakingProduction
Solasto Corporation
Tier 1RuleThroughput-Bound ConversionFlowProduction
Hospital Mater Dei S.A.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Bangkok Chain Hospital Public Company Limited
Tier 1RuleThroughput-Bound ConversionProductionRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Sinopec Oilfield Service Corporation
2 interpretationsPartial Recovery After Sharp DeclineWithin or Near the Altman Distress Zone
Sichuan Golden Summit Group Joint-stock Co. Ltd.
2 interpretationsPartial Recovery After Sharp DeclineWithin or Near the Altman Distress Zone
Zhejiang Bangjie Holding Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineWithin or Near the Altman Distress Zone